Market Report, "Sri Lanka Pharmaceuticals & Healthcare Report Q1 2013", Published
BMI View: Sri Lanka's negative pharmaceutical trade balance is expected to widen over the next five years. In an attempt to reduce medical costs, the government announced in its 2011 budget that pharmaceutical products would be exempt from the port and airport levy, with the changes relating to drugs, medical devices and equipment. Although domestic manufacturing will struggle to compete with cheap medicines from India, we expect local producers to increase capacity considerably over the medium term.
View full press release